Atlas Trials

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Clinical trial NCT03354273 · COMPLETED

Trial details

NCT number
NCT03354273
Sponsor
GE Healthcare
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Coronary Artery Disease (CAD)
Start date
2018-06-05
Primary completion
2022-05-05
Enrollment
730

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.